ARCHIVES

Fisher and Redmond Subject Of Misconduct Investigation; ORI

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979

In Brief: Cancer Control Funds For Clinical Trials Intended To Upgrade Quality of Care: Terry

January 16, 1981

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004